Amneal Biosciences

Alymsys - Cost

Last Updated: April 1st, 2024

HCPCS:

Q5126

HCPCS Code Descriptor:

Injection, bevacizumab-maly, biosimilar, (alymsys), 10 mg

Medicare Payment Limit:

The Alymsys Medicare Payment Limit is $58.811

Average Sale Price:

Alymsys ASP cost available once logged in. Alymsys is a biosimilar drug making the ASP calculation more complex. Alymsys's ASP is based on the average sale price of its biosimilar reference drug.

Medicare Co-Insurance Percentage:

The Alymsys Medicare Co-insurance percentage is 20%. Alymsys's Medicare Co-insurance amount is $11.76 per HCPCS unit.

APC Code:

The Alymsys APC Code is: 9048

APC Payment Limit:

The APC Payment Limit for Alymsys is available. Login to view.

Alymsys Cost Information:

Alymsys, manufactured by Amneal Biosciences, became effective on January 1, 2023 and is associated with HCPCS Q5126. There are four NDCs aligned to Q Code: Q5126. WAC and AWP have experienced no changes since 2023 while ASP has decreased by almost 25%.

ACCESS PRICING AND MORE BY REGISTERING

Alymsys’s wholesale acquisition cost (WAC) information was last updated on:
May 26, 2022
Alymsys’s average wholesale price (AWP) information was last updated on:
May 26, 2022

Alymsys Cost Graph: